Meridian Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,050
Closed -$208K 177
2023
Q4
$208K Sell
4,050
-1,400
-26% -$73.5K 0.05% 169
2023
Q3
$316K Hold
5,450
0.08% 134
2023
Q2
$349K Sell
5,450
-1,500
-22% -$101K 0.08% 134
2023
Q1
$482K Hold
6,950
0.12% 114
2022
Q4
$500K Sell
6,950
-190
-3% -$14.3K 0.13% 113
2022
Q3
$508K Sell
7,140
-10
-0.1% -$725 0.14% 108
2022
Q2
$551K Buy
7,150
+875
+14% +$66.6K 0.15% 113
2022
Q1
$458K Buy
6,275
+950
+18% +$63.8K 0.11% 133
2021
Q4
$332K Sell
5,325
-85
-2% -$4.99K 0.08% 154
2021
Q3
$320K Buy
5,410
+85
+2% +$5.6K 0.09% 152
2021
Q2
$356K Buy
5,325
+1,470
+38% +$95.9K 0.1% 145
2021
Q1
$243K Hold
3,855
0.08% 154
2020
Q4
$239K Sell
3,855
-555
-13% -$34.1K 0.09% 156
2020
Q3
$266K Buy
4,410
+305
+7% +$18.4K 0.11% 138
2020
Q2
$241K Sell
4,105
-450
-10% -$26.9K 0.11% 144
2020
Q1
$254K Buy
4,555
+1,450
+47% +$88.6K 0.14% 115
2019
Q4
$199K Buy
+3,105
New +$178K 0.08% 156
2019
Q1
Sell
-2,485
Closed -$129K 160
2018
Q4
$129K Buy
+2,485
New +$134K 0.1% 147

Other funds holding BMY

Meridian Wealth Advisors's BMY Position: Q1 2024 in Review

Meridian Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 4,050 shares — an estimated $208K sold.

Meridian Wealth Advisors first reported a position in BMY in Q4 2018 and held it in 18 quarters. The position peaked at $551K in Q2 2022. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Meridian Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Meridian Wealth Advisors sold 4,050 Bristol-Myers Squibb shares in Q1 2024, an estimated $208K.
  • Meridian Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 18 quarters.
  • Meridian Wealth Advisors's Bristol-Myers Squibb position peaked at $551K in Q2 2022.
  • 2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Meridian Wealth Advisors's 13F filing for Q1 2024, filed 10 May 2024.